Protecting spermatogonial stem cells from chemotherapy-induced damage for fertility preservation in childhood cancer

保护精原干细胞免受化疗引起的损伤,以保存儿童癌症的生育能力

基本信息

  • 批准号:
    MR/S017151/1
  • 负责人:
  • 金额:
    $ 156.85万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Fellowship
  • 财政年份:
    2019
  • 资助国家:
    英国
  • 起止时间:
    2019 至 无数据
  • 项目状态:
    未结题

项目摘要

Childhood cancer rates have increased dramatically (38% since 1960) over recent decades and currently 1 in 500 adults (~35000 in UK) is a survivor of childhood cancer. The increasing incidence, coupled with remarkable improvements in cure rates (>80% 5-year survival), have resulted in an increase in young adults experiencing subsequent health effects of their cancer treatment. Ensuring long-term health of this new and expanding patient cohort is one of the most pressing areas of clinical need in paediatric oncology. Infertility occurs in the majority of males receiving high-dose chemotherapy with drugs known as alkylating agents. Alkylating agents are used commonly in childhood cancer and increasingly for stem cell transplant in non-malignant disorders. Unlike the situation in men, semen cryopreservation is not an option to preserve fertility in these boys as their testicles are not capable of making sperm in childhood. As a result, there is currently no established clinical option to prevent infertility in prepubertal boys receiving chemotherapy. Preservation of fertility in children receiving cancer treatment is dependent on survival of the spermatogonial stem cells (SSC) in the testicle. These stem cells will generate sperm in males after puberty. Experimental approaches for fertility preservation in children undergoing cancer treatment could include taking a biopsy of the testicle before the patient receives their treatment and storing it for future use to restore fertility, although no methods to restore fertility using this approach have been developed so far. In addition, this requires invasive surgery, may carry a risk of re-introducing malignant cells and may require artificial reproductive techniques to restore fertility. Therefore, developing strategies to protect the testicles during chemotherapy treatment would represent a major advance for the clinical care of children with cancer. The aim of this project is to understand more about the SSCs in the prepubertal human testicle and how they are affected by chemotherapy. We will determine how the chemotherapy agents enter the SSC and how this causes the cell to die. The potential for recovery of the SSC population over time following chemotherapy treatment will also be determined. Having established the mechanisms that make SSC sensitive to chemotherapy, we will develop and test drugs that can protect the SSC and allow them to survive chemotherapy. These drugs could potentially be given to the patient at the time of their chemotherapy to preserve future fertility. We have developed experimental approaches that allow us to test the effects of chemotherapy exposure on the prepubertal human testicle using tissue obtained from boys with cancer prior to receiving cancer treatment. We can combine the exposure to chemotherapy with an additional drug from a wide-range of known and newly developed drugs to identify those that protect the SSC from the chemotherapy damage. Identification of such 'chemo-protective' agents would then be taken forward into future clinical trials aimed at preserving fertility in children with cancer. We anticipate that this project will be an important step towards development of treatments that will preserve fertility in boys receiving chemotherapy treatment.
近几十年来,儿童癌症发病率急剧增加(自1960年以来为38%),目前每500名成年人中就有1人(英国约35000人)是儿童癌症的幸存者。发病率的增加,加上治愈率的显著提高(>80%的5年生存率),导致年轻人经历癌症治疗的后续健康影响的增加。确保这一新的和不断扩大的患者群体的长期健康是儿科肿瘤学临床需求的最紧迫领域之一。不孕症发生在大多数接受大剂量化疗的男性中,化疗药物被称为烷化剂。烷化剂通常用于儿童癌症,越来越多地用于非恶性疾病的干细胞移植。与男性的情况不同,精液冷冻保存不是保持这些男孩生育能力的一种选择,因为他们的睾丸在童年时期无法制造精子。因此,目前还没有确定的临床选择,以防止不育的青春期前男孩接受化疗。在接受癌症治疗的儿童中,生育能力的保持取决于睾丸中精原干细胞(SSC)的存活。这些干细胞将在青春期后在男性体内产生精子。在接受癌症治疗的儿童中保存生育能力的实验方法可以包括在患者接受治疗之前对睾丸进行活检并将其储存以供将来用于恢复生育能力,尽管迄今为止还没有开发出使用这种方法恢复生育能力的方法。此外,这需要进行侵入性手术,可能有重新引入恶性细胞的风险,并可能需要人工生殖技术来恢复生育能力。因此,制定在化疗期间保护睾丸的策略将是癌症儿童临床护理的一个重大进步。该项目的目的是了解更多关于青春期前人类睾丸中的SSCs以及它们如何受到化疗的影响。我们将确定化疗药物如何进入SSC以及如何导致细胞死亡。还将确定化疗后SSC人群随时间恢复的可能性。在建立了使SSC对化疗敏感的机制之后,我们将开发和测试可以保护SSC并使它们在化疗中存活的药物。这些药物可能在化疗时给予患者,以保留未来的生育能力。我们已经开发了实验方法,使我们能够测试化疗暴露对青春期前人类睾丸的影响,使用从接受癌症治疗前的癌症男孩中获得的组织。我们可以联合收割机将化疗暴露与来自广泛的已知和新开发的药物中的额外药物相结合,以确定那些保护SSC免受化疗损伤的药物。这种“化学保护”剂的鉴定将被用于未来的临床试验,旨在保护癌症儿童的生育能力。我们预计,这个项目将是一个重要的一步,朝着发展的治疗,将保持生育能力的男孩接受化疗治疗。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The Dynamic Transcriptional Cell Atlas of Testis Development during Human Puberty
  • DOI:
    10.1016/j.stem.2019.12.005
  • 发表时间:
    2020-02-06
  • 期刊:
  • 影响因子:
    23.9
  • 作者:
    Guo, Jingtao;Nie, Xichen;Cairns, Bradley R.
  • 通讯作者:
    Cairns, Bradley R.
Sex steroid priming for growth hormone stimulation testing in children and adolescents with short stature: A systematic review.
身材矮小儿童和青少年生长激素刺激试验的性类固醇启动:系统评价。
  • DOI:
    10.1111/cen.14862
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    3.2
  • 作者:
    Duncan G
  • 通讯作者:
    Duncan G
Can antioxidants protect against chemotherapy in a rat spermatogonial stem cell line?
  • DOI:
    10.1530/raf-21-0042
  • 发表时间:
    2021-12
  • 期刊:
  • 影响因子:
    2.1
  • 作者:
    Allen CM;Lopes F;Mitchell RT;Spears N
  • 通讯作者:
    Spears N
Klinefelter syndrome: going beyond the diagnosis.
  • DOI:
    10.1136/archdischild-2020-320831
  • 发表时间:
    2023-03
  • 期刊:
  • 影响因子:
    5.2
  • 作者:
    Butler G;Srirangalingam U;Faithfull J;Sangster P;Senniappan S;Mitchell R
  • 通讯作者:
    Mitchell R
Fertility Preservation in Childhood Cancer: Endocrine Activity in Prepubertal Human Testis Xenografts Exposed to a Pubertal Hormone Environment.
  • DOI:
    10.3390/cancers12102830
  • 发表时间:
    2020-09-30
  • 期刊:
  • 影响因子:
    5.2
  • 作者:
    Hutka M;Kadam P;Van Saen D;Homer NZM;Onofre J;Wallace WHB;Smith LB;Stukenborg JB;Goossens E;Mitchell RT
  • 通讯作者:
    Mitchell RT
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rod Mitchell其他文献

Histories of Torres Strait Islander interaction and mythological geography
托雷斯海峡岛民互动的历史和神话地理学
  • DOI:
    10.25120/qar.25.2022.3883
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    0
  • 作者:
    D. Wright;Rod Mitchell;Bronnagh Norris
  • 通讯作者:
    Bronnagh Norris
Identification and characterization of diterpene synthases in the salvinorin A biosynthetic pathway
Salvinorin A 生物合成途径中二萜合酶的鉴定和表征
  • DOI:
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Rod Mitchell
  • 通讯作者:
    Rod Mitchell
Developmental expression patterns of chemokines CXCL11, CXCL12 and their receptor CXCR7 in testes of common marmoset and human
  • DOI:
    10.1007/s00441-015-2164-1
  • 发表时间:
    2015-03-26
  • 期刊:
  • 影响因子:
    2.900
  • 作者:
    Birgit Westernströer;Daniel Langenstroth;Sabine Kliesch;Britta Troppmann;Klaus Redmann;Joni Macdonald;Rod Mitchell;Joachim Wistuba;Stefan Schlatt;Nina Neuhaus
  • 通讯作者:
    Nina Neuhaus
A comparison of species ordination results from plot and stand data
  • DOI:
    10.1007/bf00127871
  • 发表时间:
    1975-12-01
  • 期刊:
  • 影响因子:
    1.700
  • 作者:
    F. Glenn Goff;Rod Mitchell
  • 通讯作者:
    Rod Mitchell
Teaching writing skills through genre: applying the genre-based approach in Iran
通过体裁教授写作技能:在伊朗应用基于体裁的方法

Rod Mitchell的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rod Mitchell', 18)}}的其他基金

Protecting spermatogonial stem cells from chemotherapy-induced damage for fertility preservation in childhood cancer
保护精原干细胞免受化疗引起的损伤,以保存儿童癌症的生育能力
  • 批准号:
    MR/Y011783/1
  • 财政年份:
    2024
  • 资助金额:
    $ 156.85万
  • 项目类别:
    Fellowship

相似国自然基金

cPKCγ通过UCHL1/HIF-1α信号轴调控线粒体自噬促进隐睾进程中精原细胞凋亡的病理机制研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
NR2C2通过RNA结合模式调控精原细胞稳态参与精子发生的机制研究
  • 批准号:
    2025JJ50157
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
PPP6R3介导的蛋白质去磷酸化调控精原细胞分化的机制研究
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
新型组蛋白阅读器调控精原细胞分化及在男性不育中的机制研究
  • 批准号:
    24ZR1444200
  • 批准年份:
    2024
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
食蟹猴精原细胞的体外重构及调控机制研究
  • 批准号:
    32300717
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
Nat10调控精原细胞发育的分子机制研究
  • 批准号:
    32300711
  • 批准年份:
    2023
  • 资助金额:
    20 万元
  • 项目类别:
    青年科学基金项目
睾丸精原细胞及精子MasR受体作为少弱精子症潜在治疗靶点的作用及机制研究
  • 批准号:
    82301803
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
过渡期多能态精原细胞在小鼠雄性配子发育与再生中的功能与调控机制研究
  • 批准号:
    32370902
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
基于“温肾健脾”探究淫羊藿-黄芪干预Caspase/IL/GSDMD信号通路调控精原细胞焦亡的作用及机制
  • 批准号:
    82360905
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
Thy1阳性精原细胞通过外泌体调控精原干细胞增殖的机制研究
  • 批准号:
    n/a
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目

相似海外基金

Protecting spermatogonial stem cells from chemotherapy-induced damage for fertility preservation in childhood cancer
保护精原干细胞免受化疗引起的损伤,以保存儿童癌症的生育能力
  • 批准号:
    MR/Y011783/1
  • 财政年份:
    2024
  • 资助金额:
    $ 156.85万
  • 项目类别:
    Fellowship
Elucidation of cupper metabolism regulation in spermatogonial stem cells.
阐明精原干细胞中的铜代谢调节。
  • 批准号:
    23K05781
  • 财政年份:
    2023
  • 资助金额:
    $ 156.85万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Establishment of male infertility treatment by spermatogonial stem cell transplantatioon into testicular organoids
精原干细胞睾丸类器官移植治疗男性不育症的建立
  • 批准号:
    23H03036
  • 财政年份:
    2023
  • 资助金额:
    $ 156.85万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Methods for detection of dynamic intracellular signals in single adult spermatogonial stem cells
单个成体精原干细胞动态细胞内信号的检测方法
  • 批准号:
    10666116
  • 财政年份:
    2023
  • 资助金额:
    $ 156.85万
  • 项目类别:
Epigenetic control of spermatogonial stem cell self-renewal
精原干细胞自我更新的表观遗传控制
  • 批准号:
    10656855
  • 财政年份:
    2023
  • 资助金额:
    $ 156.85万
  • 项目类别:
Postnatal Development of Spermatogonial Stem Cells
精原干细胞的产后发育
  • 批准号:
    575608-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 156.85万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Spermatogonial stem cell regulation and maintenance of male fertility
精原干细胞调节和维持男性生育力
  • 批准号:
    10360087
  • 财政年份:
    2022
  • 资助金额:
    $ 156.85万
  • 项目类别:
Effects of growth and aging on spermatogonial stem cells and its niche in rat
生长和衰老对大鼠精原干细胞及其生态位的影响
  • 批准号:
    22K05952
  • 财政年份:
    2022
  • 资助金额:
    $ 156.85万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Banking on spermatogonial stem cells to safeguard Australian native fauna
依靠精原干细胞来保护澳大利亚本土动物群
  • 批准号:
    DE220100032
  • 财政年份:
    2022
  • 资助金额:
    $ 156.85万
  • 项目类别:
    Discovery Early Career Researcher Award
Mitochondrial dynamics in spermatogonial differentiation
精原细胞分化中的线粒体动力学
  • 批准号:
    10685938
  • 财政年份:
    2022
  • 资助金额:
    $ 156.85万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了